Financial Services

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

With demand for freeze-drying surging, OFD adds project management veteran Danielle Grosso to its expanding leadership team to scale operations.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

In a crowded market, JETOUR is ditching spec-sheet wars for storytelling, launching a global film series to redefine its brand as a companion for life's journeys.

Provident Bank hires industry veteran Joseph A. Tammaro, Jr. to head its Middle Market Lending, signaling a strategic move to capture regional market share.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.

A new report reveals chronic underfunding and human error leave U.S. public services dangerously exposed to relentless ransomware and phishing attacks.

A new supply agreement for the rare isotope Actinium-225 between NorthStar and BIOEMTECH promises to break a critical bottleneck in radiopharmaceutical R&D.

As AI creates data bottlenecks, Lumen launches a new Multi-Cloud Gateway and metro network expansion, aiming to simplify hybrid IT and power innovation.

Landmark study in JAMA Neurology shows BRIUMVI offers near-zero relapse rates and stable disability, reshaping long-term multiple sclerosis treatment.

A new FDA approval allows a lung cancer therapy to be given just once a month, a major shift promising to reduce clinic time and improve quality of life.

With its burn treatment gaining traction and a pivotal wound care drug in late-stage trials, MediWound prepares to make its case to Wall Street.

TMD Energy's new director, a capital markets expert, sparks a 6.6% stock gain and speculation of M&A or major fundraising on the horizon.

Valmont Industries posts strong adjusted Q4 earnings, banking on a booming infrastructure segment to counter a deep agricultural slump and fuel growth in 2026.

Sanborn's Dr. Srini Dharmapuri has been named an ASPRS Fellow for his work on accuracy standards and digital twins, shaping the future of geospatial data.

With a major new partner and $20M in funding, Westhaven Gold kicks off a record 50,000m drill campaign to unlock its Shovelnose project in BC.

Now debt-free with $14M in cash, Castellum is leveraging major Navy contracts to fuel its next phase of expansion through acquisitions and innovation.

Bausch Health heads to a key finance conference to address investor concerns over its massive debt, upcoming patent cliffs, and future strategic direction.

Citing 'prolonged underperformance,' activist investor Starboard Value seeks to replace Tripadvisor's board, igniting a battle for control.

As Pasithea Therapeutics heads to a key investor conference, all eyes are on its lead drug, PAS-004, and its potential to treat rare and complex diseases.